See more news releases in Publishing & Information Services | Health Care & Hospitals | Medical Pharmaceuticals | New Products & Services

New Publication From FDAnews Addresses Pharmaceutical Corporate Compliance

Your Compliance Concerns Are All-Encompassing -

Your Solution Should Be Too

    FALLS CHURCH, Va., Jan. 27 /PRNewswire/ -- FDAnews announced today its
 newest publication, Pharmaceutical Corporate Compliance Report, the only
 resource that provides insight into the full range of compliance risks.
     "Pharmaceutical manufacturers are under attack for more than just sales
 and marketing practices," says Cynthia Carter, president of FDAnews. "From
 drug pricing to patient privacy, from corporate accounting to research subject
 protection, more and more drug companies are facing costly and embarrassing
 litigation for what has been standard business practice."
     The pharmaceutical industry is coming under increased scrutiny on a host
 of non-FDA regulatory issues including: FTC's pledge to step up drug company
 antitrust investigations; the Accreditation Council for Continuing Education's
 restrictive new CME standards; state AG enforcement initiatives; the Sarbanes-
 Oxley; HIPAA privacy and Qui Tam actions.
     Published biweekly, each issue of Pharmaceutical Corporate Compliance
 Report goes beyond the news to answer critical compliance questions drug
 companies are asking, and provides guidelines for developing, monitoring and
 managing effective compliance programs. Benefit from Pharmaceutical Corporate
 Compliance Report's staff of regulatory and legislative reporters, as well as
 the insight of compliance experts including industry compliance and ethics
 officers, attorneys, consultants and government officials who specialize in
 the issues you're facing today ... and will face tomorrow.
     For a limited time, FDAnews is offering Pharmaceutical Corporate
 Compliance Report at a special pre-publication rate of $697, $100 off the
 regular $797 subscription rate. For subscription information, call toll-free
 (888) 838-5578, +1 (703) 538-7600 or visit http://www.fdanews.com/wbi/pccr/.
 
     * Premiere issue April 2003
 
     Pharmaceutical Corporate Compliance Report is published by FDAnews,
 publishers of Drug Industry Daily, Washington Drug Letter, Part 11 Compliance
 Report, Generic Line, Devices & Diagnostics Letter and many other information
 services to help pharmaceutical, biotech and medical device executives meet
 legal, regulatory and business challenges.
 
 

SOURCE  FDAnews